Regulatory News
Monday, August 15, 2016
BRIEF-Aveo initiates evaluation of Tivozanib in combination with Bristol-Myers Squibb's opdivo in advanced renal cell carcinoma
* Initiates Evaluation Of Tivozanib In Combination With
Bristol Myers Squibb's Opdivo (nivolumab) in advanced renal
cell carcinoma
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment